Pharmx Technologies Ltd (PHX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Pharmx Technologies Ltd (PHX) has a cash flow conversion efficiency ratio of -0.552x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-8.91 Million ≈ $-6.30 Million USD) by net assets (AU$16.15 Million ≈ $11.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PHX equity to assets ratio to measure how much of total assets are equity-financed.
Pharmx Technologies Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Pharmx Technologies Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Pharmx Technologies Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Pharmx Technologies Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pharmx Technologies Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BTCS Inc
NASDAQ:BTCS
|
-0.011x |
|
Orad-M
TA:ORAD
|
0.098x |
|
Changhae Ethanol Co. Ltd
KQ:004650
|
0.102x |
|
Spectral AI Inc.
NASDAQ:MDAI
|
0.305x |
|
Precision Optics Corporation, Inc. Common stock
NASDAQ:POCI
|
-0.036x |
|
Premium Snacks Nordic AB
ST:SNX
|
0.133x |
|
Jourdeness Group Ltd
TW:4190
|
0.101x |
|
CTCBIO Inc
KQ:060590
|
0.079x |
Annual Cash Flow Conversion Efficiency for Pharmx Technologies Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Pharmx Technologies Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Pharmx Technologies Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-06-30 | AU$15.97 Million ≈ $11.30 Million |
AU$3.21 Million ≈ $2.27 Million |
0.201x | -59.28% |
| 2023-06-30 | AU$22.21 Million ≈ $15.72 Million |
AU$10.94 Million ≈ $7.74 Million |
0.493x | +421.33% |
| 2022-06-30 | AU$23.20 Million ≈ $16.42 Million |
AU$2.19 Million ≈ $1.55 Million |
0.095x | -31.46% |
| 2021-06-30 | AU$22.93 Million ≈ $16.22 Million |
AU$3.16 Million ≈ $2.24 Million |
0.138x | +393.18% |
| 2020-06-30 | AU$13.20 Million ≈ $9.34 Million |
AU$369.00K ≈ $261.09K |
0.028x | -79.21% |
| 2019-06-30 | AU$10.02 Million ≈ $7.09 Million |
AU$1.35 Million ≈ $953.80K |
0.135x | +476.38% |
| 2018-06-30 | AU$14.23 Million ≈ $10.07 Million |
AU$332.00K ≈ $234.91K |
0.023x | +30.98% |
| 2017-06-30 | AU$13.98 Million ≈ $9.89 Million |
AU$249.00K ≈ $176.18K |
0.018x | +127.93% |
| 2016-06-30 | AU$19.91 Million ≈ $14.09 Million |
AU$-1.27 Million ≈ $-898.61K |
-0.064x | -135.99% |
| 2015-06-30 | AU$19.93 Million ≈ $14.10 Million |
AU$3.53 Million ≈ $2.50 Million |
0.177x | -41.07% |
| 2014-06-30 | AU$18.87 Million ≈ $13.35 Million |
AU$5.68 Million ≈ $4.02 Million |
0.301x | -25.59% |
| 2013-06-30 | AU$16.36 Million ≈ $11.57 Million |
AU$6.61 Million ≈ $4.68 Million |
0.404x | -7.53% |
| 2012-06-30 | AU$10.68 Million ≈ $7.55 Million |
AU$4.67 Million ≈ $3.30 Million |
0.437x | -44.72% |
| 2011-06-30 | AU$4.65 Million ≈ $3.29 Million |
AU$3.67 Million ≈ $2.60 Million |
0.791x | +1.31% |
| 2010-06-30 | AU$2.90 Million ≈ $2.05 Million |
AU$2.26 Million ≈ $1.60 Million |
0.780x | -10.54% |
| 2008-06-30 | AU$5.11 Million ≈ $3.61 Million |
AU$4.46 Million ≈ $3.15 Million |
0.872x | +148.45% |
| 2007-06-30 | AU$7.55 Million ≈ $5.34 Million |
AU$2.65 Million ≈ $1.88 Million |
0.351x | -- |
About Pharmx Technologies Ltd
PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering and invoicing gateway; PharmX Marketplace, an e-commerce ordering platform; PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limi… Read more